Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy.
Autor: | Jahncke JN; Neuroscience Graduate Program, Oregon Health & Science University, Portland, United States., Miller DS; Neuroscience Graduate Program, Oregon Health & Science University, Portland, United States., Krush M; Neuroscience Graduate Program, Oregon Health & Science University, Portland, United States., Schnell E; Operative Care Division, Portland VA Health Care System, Portland, United States.; Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, United States., Wright KM; Vollum Institute, Oregon Health & Science University, Portland, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | ELife [Elife] 2024 Jan 05; Vol. 12. Date of Electronic Publication: 2024 Jan 05. |
DOI: | 10.7554/eLife.87965 |
Abstrakt: | Dystroglycan (Dag1) is a transmembrane glycoprotein that links the extracellular matrix to the actin cytoskeleton. Mutations in Dag1 or the genes required for its glycosylation result in dystroglycanopathy, a type of congenital muscular dystrophy characterized by a wide range of phenotypes including muscle weakness, brain defects, and cognitive impairment. We investigated interneuron (IN) development, synaptic function, and associated seizure susceptibility in multiple mouse models that reflect the wide phenotypic range of dystroglycanopathy neuropathology. Mice that model severe dystroglycanopathy due to forebrain deletion of Dag1 or Pomt2 , which is required for Dystroglycan glycosylation, show significant impairment of CCK + /CB Competing Interests: JJ, DM, MK, ES, KW No competing interests declared |
Databáze: | MEDLINE |
Externí odkaz: |